secwatch.observer — SEC 8-K summary
======================================

Issuer:     STAAR SURGICAL CO (STAA)
CIK:        0000718937
Form:       8-K
Filed at:   2023-02-21T23:59:59+00:00
Accession:  0001564590-23-002118
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STAAR Surgical Q4 net sales $64M, ICL units +20% YoY; FY2023 ICL sales guidance ~$340M
--------------------------------------------------------------------------------

- Q4 net sales $64.0M (+9% YoY); constant currency net sales $67.9M (+15%).
- ICL sales $61.2M (+15% YoY); ICL units +20% YoY; U.S. ICL units +109%.
- FY2022 net sales $284.4M (+23%); ICL sales $269.7M (+27%); ICL units +33%.
- FY2022 GAAP EPS $0.78 vs $0.50 prior year; adjusted EPS $1.22 vs $0.87.
- FY2023 ICL sales guidance ~$340M, representing 26% YoY growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/718937/000156459023002118/0001564590-23-002118-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/718937/000156459023002118/staa-8k_20230221.htm
  HTML page:      https://secwatch.observer/filing/0001564590-23-002118

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer